Luyan Pharma Co.,Ltd.’s Net Profit Rose 13.4% in First Half of 2022

Luyan Pharma Co.,Ltd. (鹭燕医药股份有限公司) (002788.SZ) reported a net profit of 169.4 million yuan in the first half of 2022, up 13.4% year-on-year.

Meanwhile, the company posted 9.3 billion yuan in revenue, up 10.2% year-on-year.

At the end of the reporting period, it had 10.6 billion yuan in total assets and 7.9 billion yuan in total liabilities, with a liability-to-asset ratio of 74.3%.